Fresenius Medical Care reported EUR1.35B in Gross Profit on Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Akzo Nobel AKZA:NA EUR 931M 47M
Alcon AG ALC:SW USD 1.17B 5M
AstraZeneca AZN:LN USD 8.7B 168M
Bayer BAYN:GR EUR 7.23B 198M
Davita Healthcare Partners DVA:US USD 828.21M 34.93M
Fresenius FRE:GR EUR 2.78B 79M
Fresenius Medical Care FME:GR EUR 1.35B 10.59M
Fresenius Medical Care FMS:US EUR 1.35B 10.59M
Getinge GETIB:SS SEK 3.83B 447M
Givaudan GIVN:VX CHF 1.3B 156M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
GN Store Nord GN:DC DKK 2.54B 189M
Hikma Pharmaceutical HIK:LN USD 642M 19M
Merck MRK:GR EUR 3.38B 283M
Novartis NOVN:VX USD 9.16B 21M
Philips PHIA:NA EUR 2.22B 491M
Roche Holding ROG:VX 22.04B 696M
Smith & Nephew PLC SN/:LN 1.83B 49M
William Demant Holding WDH:DC DKK 7.59B 503M